nodes	percent_of_prediction	percent_of_DWPC	metapath
Vidarabine—Back distress—Mesalazine—Crohn's disease	0.119	0.236	CcSEcCtD
Vidarabine—DPP4—mouth—Crohn's disease	0.0456	0.114	CbGeAlD
Vidarabine—Gastrointestinal discomfort—Azathioprine—Crohn's disease	0.0414	0.0822	CcSEcCtD
Vidarabine—Azacitidine—DNMT3A—Crohn's disease	0.0302	0.317	CrCbGaD
Vidarabine—Decitabine—DNMT3A—Crohn's disease	0.0295	0.31	CrCbGaD
Vidarabine—ADA—mammalian vulva—Crohn's disease	0.0291	0.0726	CbGeAlD
Vidarabine—DPP4—epithelium—Crohn's disease	0.0266	0.0663	CbGeAlD
Vidarabine—ADK—smooth muscle tissue—Crohn's disease	0.0264	0.0659	CbGeAlD
Vidarabine—ADK—skin of body—Crohn's disease	0.026	0.065	CbGeAlD
Vidarabine—ADA—lymphoid tissue—Crohn's disease	0.0258	0.0644	CbGeAlD
Vidarabine—DPP4—smooth muscle tissue—Crohn's disease	0.0256	0.0639	CbGeAlD
Vidarabine—ADA—digestive system—Crohn's disease	0.0255	0.0636	CbGeAlD
Vidarabine—ADK—mammalian vulva—Crohn's disease	0.0238	0.0593	CbGeAlD
Vidarabine—ADORA2A—lymphoid tissue—Crohn's disease	0.0235	0.0586	CbGeAlD
Vidarabine—DPP4—mammalian vulva—Crohn's disease	0.023	0.0575	CbGeAlD
Vidarabine—Sinus tachycardia—Mesalazine—Crohn's disease	0.0213	0.0422	CcSEcCtD
Vidarabine—ADK—lymphoid tissue—Crohn's disease	0.0211	0.0526	CbGeAlD
Vidarabine—DPP4—lymphoid tissue—Crohn's disease	0.0205	0.051	CbGeAlD
Vidarabine—DPP4—digestive system—Crohn's disease	0.0202	0.0504	CbGeAlD
Vidarabine—Adenosine triphosphate—HSPA1B—Crohn's disease	0.0159	0.167	CrCbGaD
Vidarabine—Micturition urgency—Mesalazine—Crohn's disease	0.0151	0.03	CcSEcCtD
Vidarabine—ADA—lymph node—Crohn's disease	0.0146	0.0364	CbGeAlD
Vidarabine—Glucosamine—IFNG—Crohn's disease	0.0139	0.146	CrCbGaD
Vidarabine—Burning sensation—Mesalazine—Crohn's disease	0.0123	0.0245	CcSEcCtD
Vidarabine—ADK—lymph node—Crohn's disease	0.0119	0.0297	CbGeAlD
Vidarabine—DPP4—lymph node—Crohn's disease	0.0115	0.0288	CbGeAlD
Vidarabine—Scotoma—Mesalazine—Crohn's disease	0.0113	0.0224	CcSEcCtD
Vidarabine—Intracranial pressure increased—Prednisone—Crohn's disease	0.0109	0.0215	CcSEcCtD
Vidarabine—Atrial fibrillation—Mesalazine—Crohn's disease	0.00656	0.013	CcSEcCtD
Vidarabine—Affect lability—Mesalazine—Crohn's disease	0.00612	0.0121	CcSEcCtD
Vidarabine—Mood swings—Mesalazine—Crohn's disease	0.00589	0.0117	CcSEcCtD
Vidarabine—Glucosamine—TNF—Crohn's disease	0.00581	0.061	CrCbGaD
Vidarabine—Abdominal discomfort—Azathioprine—Crohn's disease	0.00566	0.0112	CcSEcCtD
Vidarabine—Bronchospasm—Mesalazine—Crohn's disease	0.00529	0.0105	CcSEcCtD
Vidarabine—Abdominal discomfort—Mesalazine—Crohn's disease	0.00515	0.0102	CcSEcCtD
Vidarabine—Musculoskeletal discomfort—Mercaptopurine—Crohn's disease	0.00513	0.0102	CcSEcCtD
Vidarabine—Pollakiuria—Mesalazine—Crohn's disease	0.00497	0.00985	CcSEcCtD
Vidarabine—Sweating—Mesalazine—Crohn's disease	0.00459	0.00912	CcSEcCtD
Vidarabine—Mediastinal disorder—Azathioprine—Crohn's disease	0.00426	0.00845	CcSEcCtD
Vidarabine—Arrhythmia—Azathioprine—Crohn's disease	0.00422	0.00837	CcSEcCtD
Vidarabine—Hypersensitivity—Mercaptopurine—Crohn's disease	0.00415	0.00823	CcSEcCtD
Vidarabine—Tinnitus—Mesalazine—Crohn's disease	0.00401	0.00796	CcSEcCtD
Vidarabine—Cardiac disorder—Mesalazine—Crohn's disease	0.00399	0.00792	CcSEcCtD
Vidarabine—Mediastinal disorder—Mesalazine—Crohn's disease	0.00388	0.00769	CcSEcCtD
Vidarabine—Tension—Mesalazine—Crohn's disease	0.00368	0.00729	CcSEcCtD
Vidarabine—Dysgeusia—Mesalazine—Crohn's disease	0.00367	0.00728	CcSEcCtD
Vidarabine—Nervousness—Mesalazine—Crohn's disease	0.00364	0.00722	CcSEcCtD
Vidarabine—Back pain—Mesalazine—Crohn's disease	0.00362	0.00719	CcSEcCtD
Vidarabine—Vomiting—Mercaptopurine—Crohn's disease	0.00358	0.0071	CcSEcCtD
Vidarabine—Rash—Mercaptopurine—Crohn's disease	0.00355	0.00705	CcSEcCtD
Vidarabine—Dermatitis—Mercaptopurine—Crohn's disease	0.00355	0.00704	CcSEcCtD
Vidarabine—Vision blurred—Mesalazine—Crohn's disease	0.00353	0.007	CcSEcCtD
Vidarabine—Tremor—Mesalazine—Crohn's disease	0.00351	0.00696	CcSEcCtD
Vidarabine—Discomfort—Azathioprine—Crohn's disease	0.00346	0.00686	CcSEcCtD
Vidarabine—Angioedema—Mesalazine—Crohn's disease	0.00342	0.00679	CcSEcCtD
Vidarabine—Cardiac failure—Prednisone—Crohn's disease	0.00337	0.00669	CcSEcCtD
Vidarabine—Syncope—Mesalazine—Crohn's disease	0.00336	0.00666	CcSEcCtD
Vidarabine—Nausea—Mercaptopurine—Crohn's disease	0.00335	0.00664	CcSEcCtD
Vidarabine—Palpitations—Mesalazine—Crohn's disease	0.00331	0.00657	CcSEcCtD
Vidarabine—Loss of consciousness—Mesalazine—Crohn's disease	0.00329	0.00653	CcSEcCtD
Vidarabine—Cough—Mesalazine—Crohn's disease	0.00327	0.00648	CcSEcCtD
Vidarabine—Affect lability—Prednisone—Crohn's disease	0.00324	0.00643	CcSEcCtD
Vidarabine—Hypertension—Mesalazine—Crohn's disease	0.00323	0.00642	CcSEcCtD
Vidarabine—Chest pain—Mesalazine—Crohn's disease	0.00319	0.00633	CcSEcCtD
Vidarabine—Anxiety—Mesalazine—Crohn's disease	0.00318	0.0063	CcSEcCtD
Vidarabine—Discomfort—Mesalazine—Crohn's disease	0.00315	0.00625	CcSEcCtD
Vidarabine—Hypotension—Azathioprine—Crohn's disease	0.00314	0.00622	CcSEcCtD
Vidarabine—Cardiac arrest—Prednisone—Crohn's disease	0.00313	0.00621	CcSEcCtD
Vidarabine—Dry mouth—Mesalazine—Crohn's disease	0.00312	0.00619	CcSEcCtD
Vidarabine—Mood swings—Prednisone—Crohn's disease	0.00312	0.00618	CcSEcCtD
Vidarabine—Musculoskeletal discomfort—Azathioprine—Crohn's disease	0.00306	0.00607	CcSEcCtD
Vidarabine—Anaphylactic shock—Mesalazine—Crohn's disease	0.00306	0.00606	CcSEcCtD
Vidarabine—Shock—Mesalazine—Crohn's disease	0.00301	0.00597	CcSEcCtD
Vidarabine—Tachycardia—Mesalazine—Crohn's disease	0.00298	0.00592	CcSEcCtD
Vidarabine—Hyperhidrosis—Mesalazine—Crohn's disease	0.00295	0.00586	CcSEcCtD
Vidarabine—Hypotension—Mesalazine—Crohn's disease	0.00286	0.00567	CcSEcCtD
Vidarabine—Musculoskeletal discomfort—Mesalazine—Crohn's disease	0.00278	0.00553	CcSEcCtD
Vidarabine—Paraesthesia—Mesalazine—Crohn's disease	0.00274	0.00545	CcSEcCtD
Vidarabine—Dyspnoea—Mesalazine—Crohn's disease	0.00273	0.00541	CcSEcCtD
Vidarabine—Somnolence—Mesalazine—Crohn's disease	0.00272	0.00539	CcSEcCtD
Vidarabine—Pain—Mesalazine—Crohn's disease	0.00261	0.00519	CcSEcCtD
Vidarabine—Acute coronary syndrome—Prednisone—Crohn's disease	0.0025	0.00496	CcSEcCtD
Vidarabine—Myocardial infarction—Prednisone—Crohn's disease	0.00249	0.00493	CcSEcCtD
Vidarabine—Hypersensitivity—Azathioprine—Crohn's disease	0.00247	0.00491	CcSEcCtD
Vidarabine—Urticaria—Mesalazine—Crohn's disease	0.00243	0.00482	CcSEcCtD
Vidarabine—Bradycardia—Prednisone—Crohn's disease	0.00232	0.0046	CcSEcCtD
Vidarabine—Hypersensitivity—Mesalazine—Crohn's disease	0.00225	0.00447	CcSEcCtD
Vidarabine—Dizziness—Azathioprine—Crohn's disease	0.00222	0.0044	CcSEcCtD
Vidarabine—Asthenia—Mesalazine—Crohn's disease	0.00219	0.00435	CcSEcCtD
Vidarabine—Vomiting—Azathioprine—Crohn's disease	0.00213	0.00423	CcSEcCtD
Vidarabine—Rash—Azathioprine—Crohn's disease	0.00212	0.0042	CcSEcCtD
Vidarabine—Dermatitis—Azathioprine—Crohn's disease	0.00211	0.00419	CcSEcCtD
Vidarabine—Flushing—Prednisone—Crohn's disease	0.00211	0.00419	CcSEcCtD
Vidarabine—Headache—Azathioprine—Crohn's disease	0.0021	0.00417	CcSEcCtD
Vidarabine—Arrhythmia—Prednisone—Crohn's disease	0.00203	0.00403	CcSEcCtD
Vidarabine—Dizziness—Mesalazine—Crohn's disease	0.00202	0.00401	CcSEcCtD
Vidarabine—Nausea—Azathioprine—Crohn's disease	0.00199	0.00395	CcSEcCtD
Vidarabine—Vomiting—Mesalazine—Crohn's disease	0.00194	0.00386	CcSEcCtD
Vidarabine—Rash—Mesalazine—Crohn's disease	0.00193	0.00382	CcSEcCtD
Vidarabine—Dermatitis—Mesalazine—Crohn's disease	0.00193	0.00382	CcSEcCtD
Vidarabine—Headache—Mesalazine—Crohn's disease	0.00191	0.0038	CcSEcCtD
Vidarabine—Vision blurred—Prednisone—Crohn's disease	0.00187	0.00371	CcSEcCtD
Vidarabine—Agitation—Prednisone—Crohn's disease	0.00182	0.00361	CcSEcCtD
Vidarabine—Nausea—Mesalazine—Crohn's disease	0.00182	0.0036	CcSEcCtD
Vidarabine—Angioedema—Prednisone—Crohn's disease	0.00181	0.00359	CcSEcCtD
Vidarabine—Syncope—Prednisone—Crohn's disease	0.00178	0.00353	CcSEcCtD
Vidarabine—Loss of consciousness—Prednisone—Crohn's disease	0.00174	0.00346	CcSEcCtD
Vidarabine—Convulsion—Prednisone—Crohn's disease	0.00172	0.00341	CcSEcCtD
Vidarabine—Hypertension—Prednisone—Crohn's disease	0.00171	0.00339	CcSEcCtD
Vidarabine—Anxiety—Prednisone—Crohn's disease	0.00168	0.00334	CcSEcCtD
Vidarabine—Discomfort—Prednisone—Crohn's disease	0.00167	0.00331	CcSEcCtD
Vidarabine—Anaphylactic shock—Prednisone—Crohn's disease	0.00162	0.00321	CcSEcCtD
Vidarabine—Shock—Prednisone—Crohn's disease	0.00159	0.00316	CcSEcCtD
Vidarabine—Tachycardia—Prednisone—Crohn's disease	0.00158	0.00313	CcSEcCtD
Vidarabine—Hyperhidrosis—Prednisone—Crohn's disease	0.00156	0.0031	CcSEcCtD
Vidarabine—Musculoskeletal discomfort—Prednisone—Crohn's disease	0.00147	0.00292	CcSEcCtD
Vidarabine—Paraesthesia—Prednisone—Crohn's disease	0.00145	0.00288	CcSEcCtD
Vidarabine—Urticaria—Prednisone—Crohn's disease	0.00128	0.00255	CcSEcCtD
Vidarabine—Hypersensitivity—Prednisone—Crohn's disease	0.00119	0.00236	CcSEcCtD
Vidarabine—Asthenia—Prednisone—Crohn's disease	0.00116	0.0023	CcSEcCtD
Vidarabine—Dizziness—Prednisone—Crohn's disease	0.00107	0.00212	CcSEcCtD
Vidarabine—Vomiting—Prednisone—Crohn's disease	0.00103	0.00204	CcSEcCtD
Vidarabine—Rash—Prednisone—Crohn's disease	0.00102	0.00202	CcSEcCtD
Vidarabine—Dermatitis—Prednisone—Crohn's disease	0.00102	0.00202	CcSEcCtD
Vidarabine—Headache—Prednisone—Crohn's disease	0.00101	0.00201	CcSEcCtD
Vidarabine—Nausea—Prednisone—Crohn's disease	0.000961	0.00191	CcSEcCtD
